Our in-office Semaglutide and Tirzepatide are compounded with Vitamin B-12, so with each injection you will receive a dual benefit
CMS requires providers to confirm the medication is used for weight reduction along with ongoing lifestyle changes, and that the individual met one of the following when treatment started: BMI 35 BMI 30 with conditions like HFpEF, uncontrolled hypertension, or CKD (stage 3a+) BMI 27 with prediabetes or established cardiovascular disease (e.g., prior MI, stroke, PAD) One important note: this coverage will operate outside of typical Part D plans, so the approval process will look different
Magnesium plays a critical role in cardiovascular health
By 2024, more than 645,000 prescriptions were covered by Medi-Cal across all uses of the medications
TRT, GLP-1, BHRT, and peptide therapy with a board-certified physician